Skip to content
Insider tapeLive · 5:37 PM ET
Watchlist

Steven M Paul

Director at Rapport Therapeutics, Inc. (RAPP)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$32K
Total bought / sold$974K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Oct 22SEC RAPPRapport Therapeutics, Inc. Buy 35,71477,380 held (+86%) $27.28 $974K -3.3%
  • Buy

    Director Steven M Paul bought $974K of RAPP at $27.28 — first open-market purchase in our records; raises the stake by 86%.